Literature DB >> 11175261

Cleavage of eukaryotic translation initiation factor 4GII correlates with translation inhibition during apoptosis.

W E Marissen1, A Gradi, N Sonenberg, R E Lloyd.   

Abstract

Eukaryotic translation initiation factor 4G (eIF4G), which has two homologs known as eIF4GI and eIF4GII, functions in a complex (eIF4F) which binds to the 5' cap structure of cellular mRNAs and facilitates binding of capped mRNA to 40S ribosomal subunits. Disruption of this complex in enterovirus-infected cells through eIF4G cleavage is known to block this step of translation initiation, thus leading to a drastic inhibition of cap-dependent translation. Here, we show that like eIF4GI, the newly identified homolog eIF4GII is cleaved during apoptosis in HeLa cells and can serve as a substrate for caspase 3. Proteolysis of both eIF4GI and eIF4GII occurs with similar kinetics and coincides with the profound translation inhibition observed in cisplatin-treated HeLa cells. Both eIF4GI and eIF4GII can be cleaved by caspase 3 with similar efficiency in vitro, however, eIF4GII is processed into additional fragments which destroy its core central domain and likely contributes to the shutoff of translation observed in apoptosis. Cell Death and Differentiation (2000) 7, 1234 - 1243.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11175261     DOI: 10.1038/sj.cdd.4400750

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  21 in total

Review 1.  Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis.

Authors:  Linda Yip; C Garrison Fathman
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

2.  Direct ribosomal binding by a cellular inhibitor of translation.

Authors:  Daniel A Colón-Ramos; Christina L Shenvi; Douglas H Weitzel; Eugene C Gan; Robert Matts; Jamie Cate; Sally Kornbluth
Journal:  Nat Struct Mol Biol       Date:  2006-01-22       Impact factor: 15.369

Review 3.  Role of translation initiation factor 4G in lifespan regulation and age-related health.

Authors:  Amber Howard; Aric N Rogers
Journal:  Ageing Res Rev       Date:  2014-01-03       Impact factor: 10.895

4.  Proteins regulating cap-dependent translation are downregulated during total knee arthroplasty.

Authors:  Stephen M Ratchford; Ashley N Bailey; Hilary A Senesac; Austin D Hocker; Keith Smolkowski; Brick A Lantz; Brian A Jewett; Jeffrey S Gilbert; Hans C Dreyer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-28       Impact factor: 3.619

5.  Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency.

Authors:  Shunan Li; Nahum Sonenberg; Anne-Claude Gingras; Mark Peterson; Svetlana Avdulov; Vitaly A Polunovsky; Peter B Bitterman
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  Viral subversion of host functions for picornavirus translation and RNA replication.

Authors:  Amanda J Chase; Bert L Semler
Journal:  Future Virol       Date:  2012-02       Impact factor: 1.831

7.  Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells.

Authors:  Miguel Zamora; Wilfred E Marissen; Richard E Lloyd
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

8.  Translation of cellular inhibitor of apoptosis protein 1 (c-IAP1) mRNA is IRES mediated and regulated during cell stress.

Authors:  Marc E Van Eden; Marshall P Byrd; Kyle W Sherrill; Richard E Lloyd
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

9.  Generation of multiple isoforms of eukaryotic translation initiation factor 4GI by use of alternate translation initiation codons.

Authors:  Marshall P Byrd; Miguel Zamora; Richard E Lloyd
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3.

Authors:  Linda Yip; Remi J Creusot; Cara T Pager; Peter Sarnow; C Garrison Fathman
Journal:  J Mol Cell Biol       Date:  2012-08-24       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.